Go to content
Careers
News & Insights
Contact
Search
Strategy
Toggle submenu
The Acuitas Advantage
Our Partnerships
Our Capabilities
Science
Toggle submenu
Our LNP Technology
Our Clinical Applications
Company
Toggle submenu
About Us
Our Team
Our Community Impact
Home
News
Article
April 21, 2025
Identification of Novel Lipids with Improved Activity for Prophylactic Vaccine Development
Dr. Thomas Chamberlain, Senior Research Scientist I
World Vaccine Congress, Washington, DC
Previous
Page:
/
Next
Fullscreen
Download PDF
Close
Return to Presentations